Your browser doesn't support javascript.
loading
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.
Chari, Ajai; Samur, Mehmet Kemal; Martinez-Lopez, Joaquin; Cook, Gordon; Biran, Noa; Yong, Kwee; Hungria, Vania; Engelhardt, Monika; Gay, Francesca; García Feria, Ana; Oliva, Stefania; Oostvogels, Rimke; Gozzetti, Alessandro; Rosenbaum, Cara; Kumar, Shaji; Stadtmauer, Edward A; Einsele, Hermann; Beksac, Meral; Weisel, Katja; Anderson, Kenneth C; Mateos, María-Victoria; Moreau, Philippe; San-Miguel, Jesus; Munshi, Nikhil C; Avet-Loiseau, Hervé.
Affiliation
  • Chari A; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Samur MK; Dana-Farber Cancer Institute, Boston, MA.
  • Martinez-Lopez J; Department of Data Science, Harvard T. H. Chan School of Public Health, Boston, MA.
  • Cook G; Instituto de Investigación, Hospital Universitario 12 de Octubre (i+12), Madrid, Spain.
  • Biran N; Centro Nacional de Investigaciones Oncológicas (CNIO), Complutense University, Madrid, Spain.
  • Yong K; Leeds Institute of Clinical Trial Research and.
  • Hungria V; Leeds Cancer Centre, University of Leeds, Leeds, United Kingdom.
  • Engelhardt M; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
  • Gay F; Department of Haematology, University College London Hospitals National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • García Feria A; Clínica São Germano, São Paulo, Brazil.
  • Oliva S; Medical Department.
  • Oostvogels R; Hematology, Oncology and Stem Cell Transplantation, and.
  • Gozzetti A; Clinical Cancer Research Group, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Rosenbaum C; Myeloma Unit, Division of Hematology, University of Turin/Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
  • Kumar S; Department of Hematology, Hospital de Manises, Valencia, Spain.
  • Stadtmauer EA; Hematology Laboratory, University of Turin, Turin, Italy.
  • Einsele H; Department of Haematology, University Medical Centre, Utrecht, The Netherlands.
  • Beksac M; Department of Hematology, University of Siena, Siena, Italy.
  • Weisel K; Center for Myeloma, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY.
  • Anderson KC; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Mateos MV; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Moreau P; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
  • San-Miguel J; Department of Hematology, Ankara University, Ankara, Turkey.
  • Munshi NC; II Medizinische Klinik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Avet-Loiseau H; Dana-Farber Cancer Institute, Boston, MA.
Blood ; 136(26): 3033-3040, 2020 12 24.
Article in En | MEDLINE | ID: mdl-33367546
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Societies, Medical / Internationality / SARS-CoV-2 / COVID-19 / Multiple Myeloma Type of study: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2020 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Societies, Medical / Internationality / SARS-CoV-2 / COVID-19 / Multiple Myeloma Type of study: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2020 Type: Article